SEC Form 4 · accession 0001104659-26-104728
Zenas BioPharma, Inc. · ZBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christy J. Oliger
Director
Period of report
Sep 1, 2026
Accepted (ET)
Sep 2, 2026 · 4:02 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001953926
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $31.98 | Sep 1, 2026 | A | 37,000 | A | — | Aug 31, 2036 | Common Stock | 37,000 | 37,000 | D |
Explanation of responses
- F1The option vests in equal annual installments over three years beginning on September 1, 2027, the first anniversary of the vesting commencement date, subject to continued service.